| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Unidade de Endocrinologia do Desenvolvimento e Laboratório de Hormônios e Genética Molecular, LIM/42, Disciplina de Endocrinologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (M.G.F.O., S.M., A.C.L., B.B.M., I.J.P.A.), Sao Paulo, Brazil; and Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University (P.K.), Chicago, Illinois 60611
Address all correspondence and requests for reprints: Ivo J. P. Arnhold, M.D., Disciplina de Endocrinologia, Hospital das Clínicas, Caixa Postal 3671, CEP 01065970, São Paulo, Brazil. E-mail: iarnhold{at}usp.br
Mutations in the pituitary-specific paired-like homeodomain transcription factor, PROP-1, result in combined pituitary hormone deficiency. We studied a Brazilian girl, offspring of first cousins, who presented with short stature and deficiencies of GH, TSH, PRL, LH, and FSH. Her cortisol response to hypoglycemia was determined at age 4.9, 10.7, and 14.1 yr and remained normal. Magnetic resonance imaging at the age of 9 yr revealed an anterior pituitary lobe of diminished height (3 mm; normal, 4.5 ± 0.6), but radiography revealed a sella turcica volume above the normal mean.
Direct sequencing of the PROP-1 gene revealed homozygosity for a novel 263T>C transition that results in the replacement of a highly conserved phenylalanine by serine at codon 88 (F88S). F88 constitutes the hydrophobic core of the first helix of the homeodomain of PROP-1, and the substitution by the polar residue serine is expected to alter the secondary structure and impair binding of the mutated PROP-1 to DNA target sequences. The F88S mutation (which corresponds to murine F85S) was introduced into the murine Prop-1 complementary DNA and its consequences on DNA binding and trans-activation were assessed in vitro. In contrast to wild-type Prop-1, the F88S mutant showed no significant DNA binding to a PRDQ9 Prop-1 response element in gel shift assays. Transcriptional activation of a luciferase reporter gene containing a PRDQ9 site upstream of a simian virus 40 promoter was reduced to approximately 34% compared with that of wild-type Prop-1 in transiently transfected TSA-201 human embryonic kidney cells. The F88S mutation further expands the repertoire of mutations in PROP-1.
This article has been cited by other articles:
![]() |
D. Kelberman and M. T. Dattani Hypothalamic and pituitary development: novel insights into the aetiology Eur. J. Endocrinol., August 1, 2007; 157(suppl_1): S3 - S14. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Heathcote, C. Braybrook, L. Abushaban, M. Guy, M. E. Khetyar, M. A. Patton, N. D. Carter, P. J. Scambler, and P. Syrris Common arterial trunk associated with a homeodomain mutation of NKX2.6 Hum. Mol. Genet., March 1, 2005; 14(5): 585 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Reynaud, M. Chadli-Chaieb, S. Vallette-Kasic, A. Barlier, J. Sarles, I. Pellegrini-Bouiller, A. Enjalbert, L. Chaieb, and T. Brue A Familial Form of Congenital Hypopituitarism Due to a PROP1 Mutation in a Large Kindred: Phenotypic and in Vitro Functional Studies J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5779 - 5786. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Lee, Y.-S. Zhu, J. J. Cordero, L.-Q. Cai, I. Labour, C. Herrera, and J. Imperato-McGinley Long-Term Growth Hormone Therapy in Adulthood Results in Significant Linear Growth in Siblings with a PROP-1 Gene Mutation J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4850 - 4856. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Voutetakis, M. Argyropoulou, A. Sertedaki, S. Livadas, P. Xekouki, M. Maniati-Christidi, I. Bossis, N. Thalassinos, N. Patronas, and C. Dacou-Voutetakis Pituitary Magnetic Resonance Imaging in 15 Patients with Prop1 Gene Mutations: Pituitary Enlargement May Originate from the Intermediate Lobe J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2200 - 2206. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Cohen, L. E. Cohen, D. Botero, C. Yu, A. Sagar, M. Jurkiewicz, and S. Radovick Enhanced Repression by HESX1 as a Cause of Hypopituitarism and Septooptic Dysplasia J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4832 - 4839. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Vieira, M. R. Dias da Silva, J. M. Cerutti, E. Brunner, M. Borges, L. T. Arnaldi, P. Kopp, and J. Abucham Familial Combined Pituitary Hormone Deficiency due to a Novel Mutation R99Q in the Hot Spot Region of Prophet of Pit-1 Presenting as Constitutional Growth Delay J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 38 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. F. Osorio, S. Marui, A. A. L. Jorge, A. C. Latronico, L. S. S. Lo, C. C. Leite, V. Estefan, B. B. Mendonca, and I. J. P. Arnhold Pituitary Magnetic Resonance Imaging and Function in Patients with Growth Hormone Deficiency with and without Mutations in GHRH-R, GH-1, or PROP-1 Genes J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5076 - 5084. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Cohen and S. Radovick Molecular Basis of Combined Pituitary Hormone Deficiencies Endocr. Rev., August 1, 2002; 23(4): 431 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vallette-Kasic, A. Barlier, C. Teinturier, A. Diaz, M. Manavela, F. Berthezene, P. Bouchard, J. L. Chaussain, R. Brauner, I. Pellegrini-Bouiller, et al. PROP1 Gene Screening in Patients with Multiple Pituitary Hormone Deficiency Reveals Two Sites of Hypermutability and a High Incidence of Corticotroph Deficiency J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4529 - 4535. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |